Masimo (NASDAQ:MASI) Stock Price Crosses Above 200 Day Moving Average – What’s Next?

Masimo Co. (NASDAQ:MASI)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $138.22 and traded as high as $169.66. Masimo shares last traded at $168.80, with a volume of 634,326 shares changing hands.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. BTIG Research upped their target price on shares of Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Stifel Nicolaus restated a “buy” rating and issued a $190.00 target price (up from $170.00) on shares of Masimo in a research report on Friday, November 22nd. Piper Sandler boosted their price target on Masimo from $180.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 18th. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a report on Wednesday, November 6th. Finally, Raymond James lifted their price objective on shares of Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research note on Friday, December 27th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $179.67.

Masimo Trading Up 2.0 %

The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. The firm has a 50-day moving average price of $167.18 and a 200-day moving average price of $138.22. The company has a market capitalization of $9.04 billion, a price-to-earnings ratio of 116.41 and a beta of 1.01.

Masimo (NASDAQ:MASI) last issued its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 EPS for the quarter, topping the consensus estimate of $0.84 by $0.14. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The firm had revenue of $504.60 million for the quarter, compared to analysts’ expectations of $502.87 million. During the same period in the previous year, the business earned $0.63 earnings per share. Masimo’s revenue for the quarter was up 5.4% compared to the same quarter last year. As a group, sell-side analysts predict that Masimo Co. will post 4.03 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in MASI. NBC Securities Inc. boosted its stake in shares of Masimo by 47.1% during the 3rd quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 73 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Masimo by 133.3% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 200 shares during the last quarter. GAMMA Investing LLC boosted its position in shares of Masimo by 136.5% in the 4th quarter. GAMMA Investing LLC now owns 466 shares of the medical equipment provider’s stock valued at $77,000 after purchasing an additional 269 shares during the period. HHM Wealth Advisors LLC increased its stake in Masimo by 25.0% in the 2nd quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider’s stock worth $79,000 after purchasing an additional 125 shares in the last quarter. Finally, Headlands Technologies LLC acquired a new stake in Masimo during the 2nd quarter worth about $109,000. Institutional investors and hedge funds own 85.96% of the company’s stock.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.